首页> 外文期刊>The USV Annals of Economics and Public Administration >THE R&D AND THE INTERNATIONALIZATION OF BUSINESS ORGANIZATIONS. THE CASE OF PHARMACEUTICAL COMPANIES
【24h】

THE R&D AND THE INTERNATIONALIZATION OF BUSINESS ORGANIZATIONS. THE CASE OF PHARMACEUTICAL COMPANIES

机译:企业组织的研发和国际化。制药公司案例

获取原文
           

摘要

Research and development represents one of the key activities of the business environment which shows company’s ability of continuous development. The interest in research and development can be observed in the global companies goals of being innovative by the goods and products offered. Combing these two elements helps improving company’s competitiveness which has a major contribution in the development of some strategic arias like health, energy or industry. The level of development of a company and the degree of diversification of the products and services offered is different from company to company, which highlights the fact that in the process of internationalization companies need to be focused to work on their advantages in order to keep the competition away. In these sort of cases companies decide to pay a particular attention in assigning resources for specific activities of research and development. The success of the pharmaceutical companies depends of the of research and development activity which objectives is to encourage creativity and innovation regarding the development of new medicines or other pharmaceutical products. The pharmaceutical industry would not be able to evolve without massive investments in research and development which is the base of the evolution of the company. On the other hand, the more they invest in research and development, the companies tend to expand their activity abroad in order to promote the comparative advantages obtained by the activity of research.
机译:研发是业务环境的关键活动之一,它表明了公司的持续发展能力。在全球公司的目标中,即通过所提供的商品和产品进行创新,可以观察到对研发的兴趣。将这两个要素结合在一起有助于提高公司的竞争力,这对一些战略性咏叹调(如健康,能源或工业)的发展做出了重大贡献。公司的发展水平以及所提供产品和服务的多元化程度因公司而异,这凸显了这样一个事实,即在国际化过程中,公司需要专注于发挥其优势,以保持其优势。竞争了。在这种情况下,公司决定在为特定的研发活动分配资源时要特别注意。制药公司的成功取决于研发活动,其目的是鼓励有关新药或其他药品开发的创造力和创新。没有大规模的研发投入,制药业将无法发展,而这正是公司发展的基础。另一方面,公司在研发上投入的资金越多,它们倾向于将业务扩展到国外,以促进研究活动所获得的比较优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号